Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/09/721
Active ingredient: Panobinostat
Indication: Treatment of Hodgkin's lymphoma
Sponsor: Novartis Europharm Limited
Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2010 Centralised Orphan - Designation EMEA/OD/096/09 (2010)785 of 02/02/2010
25/04/2012 Other procedure